Literature DB >> 30582455

Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.

Shohei Ikeda1,2, Wataru Mizushima1, Sebastiano Sciarretta1,3,4, Maha Abdellatif1, Peiyong Zhai1, Risa Mukai1, Nadezhda Fefelova1, Shin-Ichi Oka1, Michinari Nakamura1, Dominic P Del Re1, Iain Farrance5, Ji Yeon Park6, Bin Tian6, Lai-Hua Xie1, Mohit Kumar7, Chiao-Po Hsu8, Sakthivel Sadayappan7, Hiroaki Shimokawa2, Dae-Sik Lim9, Junichi Sadoshima1.   

Abstract

RATIONALE: The Hippo pathway plays an important role in determining organ size through regulation of cell proliferation and apoptosis. Hippo inactivation and consequent activation of YAP (Yes-associated protein), a transcription cofactor, have been proposed as a strategy to promote myocardial regeneration after myocardial infarction. However, the long-term effects of Hippo deficiency on cardiac function under stress remain unknown.
OBJECTIVE: We investigated the long-term effect of Hippo deficiency on cardiac function in the presence of pressure overload (PO). METHODS AND
RESULTS: We used mice with cardiac-specific homozygous knockout of WW45 (WW45cKO), in which activation of Mst1 (Mammalian sterile 20-like 1) and Lats2 (large tumor suppressor kinase 2), the upstream kinases of the Hippo pathway, is effectively suppressed because of the absence of the scaffolding protein. We used male mice at 3 to 4 month of age in all animal experiments. We subjected WW45cKO mice to transverse aortic constriction for up to 12 weeks. WW45cKO mice exhibited higher levels of nuclear YAP in cardiomyocytes during PO. Unexpectedly, the progression of cardiac dysfunction induced by PO was exacerbated in WW45cKO mice, despite decreased apoptosis and activated cardiomyocyte cell cycle reentry. WW45cKO mice exhibited cardiomyocyte sarcomere disarray and upregulation of TEAD1 (transcriptional enhancer factor) target genes involved in cardiomyocyte dedifferentiation during PO. Genetic and pharmacological inactivation of the YAP-TEAD1 pathway reduced the PO-induced cardiac dysfunction in WW45cKO mice and attenuated cardiomyocyte dedifferentiation. Furthermore, the YAP-TEAD1 pathway upregulated OSM (oncostatin M) and OSM receptors, which played an essential role in mediating cardiomyocyte dedifferentiation. OSM also upregulated YAP and TEAD1 and promoted cardiomyocyte dedifferentiation, indicating the existence of a positive feedback mechanism consisting of YAP, TEAD1, and OSM.
CONCLUSIONS: Although activation of YAP promotes cardiomyocyte regeneration after cardiac injury, it induces cardiomyocyte dedifferentiation and heart failure in the long-term in the presence of PO through activation of the YAP-TEAD1-OSM positive feedback mechanism.

Entities:  

Keywords:  apoptosis; cell cycle; cell proliferation; heart failure; mice

Mesh:

Substances:

Year:  2019        PMID: 30582455      PMCID: PMC6645688          DOI: 10.1161/CIRCRESAHA.118.314048

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  46 in total

1.  Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury.

Authors:  Dominic P Del Re; Yanfei Yang; Noritsugu Nakano; Jaeyeaon Cho; Peiyong Zhai; Takanobu Yamamoto; Nailing Zhang; Norikazu Yabuta; Hiroshi Nojima; Duojia Pan; Junichi Sadoshima
Journal:  J Biol Chem       Date:  2012-12-30       Impact factor: 5.157

2.  Tumor cell splice variants of the transcription factor TEF-1 induced by SV40 T-antigen transformation.

Authors:  P C Zuzarte; I K Farrance; P C Simpson; A G Wildeman
Journal:  Biochim Biophys Acta       Date:  2000-12-15

3.  Elucidation of a universal size-control mechanism in Drosophila and mammals.

Authors:  Jixin Dong; Georg Feldmann; Jianbin Huang; Shian Wu; Nailing Zhang; Sarah A Comerford; Mariana F Gayyed; Robert A Anders; Anirban Maitra; Duojia Pan
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

Review 4.  The biology of YAP/TAZ: hippo signaling and beyond.

Authors:  Stefano Piccolo; Sirio Dupont; Michelangelo Cordenonsi
Journal:  Physiol Rev       Date:  2014-10       Impact factor: 37.312

5.  Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model.

Authors:  Zhiqiang Lin; Alexander von Gise; Pingzhu Zhou; Fei Gu; Qing Ma; Jianming Jiang; Allan L Yau; Jessica N Buck; Katryna A Gouin; Pim R R van Gorp; Bin Zhou; Jinghai Chen; Jonathan G Seidman; Da-Zhi Wang; William T Pu
Journal:  Circ Res       Date:  2014-05-15       Impact factor: 17.367

6.  Hippo signaling impedes adult heart regeneration.

Authors:  Todd Heallen; Yuka Morikawa; John Leach; Ge Tao; James T Willerson; Randy L Johnson; James F Martin
Journal:  Development       Date:  2013-12       Impact factor: 6.868

7.  Hypoxia induces heart regeneration in adult mice.

Authors:  Yuji Nakada; Diana C Canseco; SuWannee Thet; Salim Abdisalaam; Aroumougame Asaithamby; Celio X Santos; Ajay M Shah; Hua Zhang; James E Faber; Michael T Kinter; Luke I Szweda; Chao Xing; Zeping Hu; Ralph J Deberardinis; Gabriele Schiattarella; Joseph A Hill; Orhan Oz; Zhigang Lu; Cheng Cheng Zhang; Wataru Kimura; Hesham A Sadek
Journal:  Nature       Date:  2016-10-31       Impact factor: 49.962

8.  Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules.

Authors:  Ji Yeon Park; Wencheng Li; Dinghai Zheng; Peiyong Zhai; Yun Zhao; Takahisa Matsuda; Stephen F Vatner; Junichi Sadoshima; Bin Tian
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

9.  Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity.

Authors:  Dongdong Sun; Shuang Li; Hao Wu; Mingming Zhang; Xiaotian Zhang; Liping Wei; Xing Qin; Erhe Gao
Journal:  J Cell Mol Med       Date:  2015-03-08       Impact factor: 5.310

10.  Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury.

Authors:  Ge Tao; Peter C Kahr; Yuka Morikawa; Min Zhang; Mahdis Rahmani; Todd R Heallen; Lele Li; Zhao Sun; Eric N Olson; Brad A Amendt; James F Martin
Journal:  Nature       Date:  2016-05-25       Impact factor: 49.962

View more
  25 in total

Review 1.  Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts.

Authors:  Cameron S Brand; Janet K Lighthouse; Michael A Trembley
Journal:  J Mol Cell Cardiol       Date:  2019-04-28       Impact factor: 5.000

Review 2.  Dedifferentiation: inspiration for devising engineering strategies for regenerative medicine.

Authors:  Yongchang Yao; Chunming Wang
Journal:  NPJ Regen Med       Date:  2020-07-31

3.  YAP plays a crucial role in the development of cardiomyopathy in lysosomal storage diseases.

Authors:  Shohei Ikeda; Jihoon Nah; Akihiro Shirakabe; Peiyong Zhai; Shin-Ichi Oka; Sebastiano Sciarretta; Kun-Liang Guan; Hiroaki Shimokawa; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

Review 4.  Role of YAP/TAZ in Energy Metabolism in the Heart.

Authors:  Toshihide Kashihara; Junichi Sadoshima
Journal:  J Cardiovasc Pharmacol       Date:  2019-12       Impact factor: 3.105

5.  Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload.

Authors:  Jaemin Byun; Dominic P Del Re; Peiyong Zhai; Shohei Ikeda; Akihiro Shirakabe; Wataru Mizushima; Shigeki Miyamoto; Joan H Brown; Junichi Sadoshima
Journal:  J Biol Chem       Date:  2019-01-11       Impact factor: 5.157

6.  The tumor suppressor RASSF1A modulates inflammation and injury in the reperfused murine myocardium.

Authors:  Jamie Francisco; Jaemin Byun; Yu Zhang; Olivia Berman Kalloo; Wataru Mizushima; Shinichi Oka; Peiyong Zhai; Junichi Sadoshima; Dominic P Del Re
Journal:  J Biol Chem       Date:  2019-07-16       Impact factor: 5.157

7.  A microRNA program regulates the balance between cardiomyocyte hyperplasia and hypertrophy and stimulates cardiac regeneration.

Authors:  Andrea Raso; Ellen Dirkx; Vasco Sampaio-Pinto; Hamid El Azzouzi; Ryan J Cubero; Daniel W Sorensen; Lara Ottaviani; Servé Olieslagers; Manon M Huibers; Roel de Weger; Sailay Siddiqi; Silvia Moimas; Consuelo Torrini; Lorena Zentillin; Luca Braga; Diana S Nascimento; Paula A da Costa Martins; Jop H van Berlo; Serena Zacchigna; Mauro Giacca; Leon J De Windt
Journal:  Nat Commun       Date:  2021-08-10       Impact factor: 17.694

Review 8.  Targeting the Hippo pathway in heart repair.

Authors:  Fansen Meng; Bing Xie; James F Martin
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

Review 9.  Molecular mechanisms of heart regeneration.

Authors:  Ana Vujic; Niranjana Natarajan; Richard T Lee
Journal:  Semin Cell Dev Biol       Date:  2019-10-04       Impact factor: 7.727

10.  Oncostatin M is a novel biomarker for coronary artery disease - A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus.

Authors:  Shohei Ikeda; Koichi Sato; Morihiko Takeda; Keita Miki; Kentaro Aizawa; Tsuyoshi Takada; Koji Fukuda; Nobuyuki Shiba
Journal:  Int J Cardiol Heart Vasc       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.